Actively Recruiting

Age: 18Years - 100Years
All Genders
NCT07029542

Home Reported Outcomes in C3G Study

Led by Novartis Pharmaceuticals · Updated on 2025-06-19

100

Participants Needed

1

Research Sites

55 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The study aims to longitudinally capture the full spectrum of symptoms, treatment utilization, and overall Health-related Quality of Life (HRQoL) experienced by C3 glomerulopathy (C3G) patients and their caregivers. By primarily utilizing home reported outcomes (HRO) data on symptom burden and treatment usage, supplemented with patient-reported outcome (PRO) measures (collected at baseline and monthly), the study seeks to establish a new real-world data (RWD) source to understand symptom variability and HRQoL as reported by C3G patients and caregivers, including those taking iptacopan

CONDITIONS

Official Title

Home Reported Outcomes in C3G Study

Who Can Participate

Age: 18Years - 100Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Clinical diagnosis of C3 glomerulopathy (C3G), regardless of symptoms, treatment, or transplant history
  • Adult aged 18 or older, or adult caregiver to an adult patient aged 18 or older
  • Adult caregiver to a pediatric patient under 18 years of age
  • Able to provide informed consent
  • Access to technology such as a mobile phone or tablet to participate in the app-based study
  • Based in the United States with proficient understanding and ability to read English
Not Eligible

You will not qualify if you...

  • Participants who do not meet all of the above inclusion criteria are not eligible
  • No other exclusion criteria apply; treatment regimen or prescription use does not exclude participation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Novartis Investigative Site

East Hanover, New Jersey, United States, 07936

Actively Recruiting

Loading map...

Research Team

N

Novartis Pharmaceuticals

CONTACT

N

Novartis Pharmaceuticals

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here